Welcome to the e-CCO Library!

OP04 Long-term outcomes after ileocolonic resection in Crohn’s disease according to the severity of early endoscopic recurrence
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Hammoudi1, C. Auzolle1, M.L. Tran Minh1, G. Boschetti2, M. Bezault3, A. Buisson4, B. Pariente5, X. Treton6, P. Seksik7, M. Fumery8, L. Le Bourhis9, S. Nancey2, M. Allez1, REMIND Study Group

Created: Thursday, 30 January 2020, 10:12 AM
OP04: Efficacy of upadacitinib in ulcerative colitis: A phase 3 post hoc analysis of biologic- and anti-TNF-inadequate response patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vermeire, S.(1)*;Danese, S.(2);Hébuterne, X.(3);D'Haens, G.(4);Takeuchi, K.(5);Finney-Hayward, T.(6);Klaff, J.(6);Holweg, C.T.J.(6);Rubin, D.T.(7);
Created: Friday, 14 July 2023, 10:43 AM
OP04: Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study
Year: 2021
Source: ECCO'21 Virtual
Authors: Schreiber, S.W.(1);Watanabe, M.(2);Yun, C.(3);Zhou, Y.(3);Zhao, S.(3);Hsieh, J.(3);Moerch, U.(4);Rogler, G.(5);Loftus Jr, E.V.(6)
Created: Wednesday, 2 June 2021, 4:12 PM
OP04: Turning sweet in inflammatory bowel disease: glycans as novel immunomodulators of T-cell-mediated immune response
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Dias1, M. Pereira1, A. Correia1, I. Alves1, V. Pinto1, L. Azevedo2, L. Maia3, R. Marcos-Pinto3, M. Vilanova1, P. Lago3, S. Pinho*1

Created: Friday, 22 February 2019, 9:41 AM
OP04: Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trial
Year: 2022
Source: ECCO'22
Authors: Travis, S.(1);Silverberg, M.S.(2);Danese, S.(3);Gionchetti, P.(4);Löwenberg, M.(5);Jairath, V.(6,7);Feagan, B.G.(7);Bressler, B.(8);Lindner, D.(9);Escher, A.(9);Jones, S.(9);Shen, B.(10);
Created: Friday, 11 February 2022, 3:52 PM
OP05 Validation of the Lémann index in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Pariente1, J. Torres2, J. Burisch3, N. Arebi4, B. Barberio5, D. Duricova6, P. Ellul7, A. Goldis8, I. Kaimakliotis9, K. Katsanos10, Z. Krznaric11, D. Mc Namara12, N. Pedersen13, S. Sebastian14, P. Weimars15, P. Lung16, C. Lacognata17, M. Horak18, V. Domislovic11, I. Murphy12, R. Ungaro19, J.F. Colombel19, J.Y. Mary20

Created: Thursday, 30 January 2020, 10:12 AM
OP05: Association of ultra-processed food intake with risk of Inflammatory Bowel Disease from the prospective urban rural epidemiology (PURE) study: A prospective cohort study
Year: 2021
Source: ECCO'21 Virtual
Authors: Narula, N.(1);Wong, E.(1);Dehghan, M.(2);Mente, A.(2);Rangarajan, S.(2);Marshall, J.(1);Moayyedi, P.(1);Reinisch, W.(3);Yusuf, S.(2)
Created: Wednesday, 2 June 2021, 4:12 PM
OP05: Crohn’s disease exclusion diet is equally effective but better tolerated than exclusive enteral nutrition for induction of remission in mild-to-moderate active paediatric Crohn’s disease: a prospective randomised controlled trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Van Limbergen1,2, E. Wine3, A. Assa4, R. Sigall Boneh5, R. Shaoul6, M. Kori7, S. Cohen8, S. Peleg9, H. Shamaly10, A. On11, P. Milman12, L. Abramas5, T. Ziv Baran13, S. Grant14, A. Levine*5,13

Created: Friday, 22 February 2019, 9:41 AM
OP05: High-dimensional single-cell analysis identifies cellular signatures associated with response to vedolizumab therapy in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pibiri, P.(1)*;Sun, S.(1);Karmi, N.(1);Oelen, R.(2);de Jong, S.(1);Bangma, A.(1);Hermoso, M.(1);Paraskevopoulou, M.(3);Farahmand, S.(3);Weersma, R.(1);Bigaeva, E.(1);Festen, E.(1);Xia, G.(3);Teunis, J.(4);Bleck, B.(3);
Created: Friday, 14 July 2023, 10:43 AM
OP05: Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study
Year: 2022
Source: ECCO'22
Authors: Shavit, Z.(1);Stein, R.(2);Aloi, M.(3);Ledder, O.(4);Focht, G.(4);Urlep, D.(5);Hyams, J.(6);Broide, E.(7);Vais, B.(8);Levine, J.(9);Shouval , D.(10);Matar, M.(10);Assa, A.(10);Rosh, J.(11);Hussey, S.(12);Markowitz, J.(13);Yerushalmy-Feler, A.(14);Miele, E.(15);Shaoul, R.(16);Russell, R.K.(17);Turner, D.(4);
Created: Friday, 11 February 2022, 3:52 PM
OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Haberman Ziv1, N. Loberman-Nachum1, S. Katya1, A. Di Segni1, G. Efroni1, T. Braun1, M. BenShoshan1, D. Shouval1, L.A. Denson2, A. Amir1, R. Unger3, B. Weiss1, CCF funded RISK Crohn Disease study

Created: Thursday, 30 January 2020, 10:12 AM
OP06: 5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry
Year: 2021
Source: ECCO'21 Virtual
Authors: Ungaro, R.(1);Brenner, E.(2);Agrawal, M.(1);Gearry, R.B.(3);Kaplan, G.G.(4);Kissous-Hunt, M.(1);Ng, S.C.(5);Rahier, J.F.(6);Reinisch, W.(7);Steinwurz, F.(8);Zhang, X.(2);Lewis, J.D.(9);Kappelman, M.D.(2);Colombel, J.F.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP06: Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Humbel1, P. Juillerat2, M. Scharl1, B. Misselwitz2, P. Schreiner1, A. Macpherson2, G. Rogler1, R. von Känel3, B. Yilmaz4, L. Biedermann*1

Created: Friday, 22 February 2019, 9:41 AM
OP06: Multiomic interrogation of the epithelium in active Ulcerative Colitis reveals dysregulated myeloid cells associated with non-response to anti-Tumour Necrosis Factor therapy.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jha , D.(1)*;Al-Taie , Z.(2);Krek , A.(3);Eshghi , S.(4);Tankelevich , M.(1);Meringer , H.(5);Cossarini , F.(6);Canales-Herrerias , P.(1);Livanos , A.E.(1); Polydorides , A.D.(7);Martin , J.(8);Ko , H.M.(9);McBride , J.(4);Hackney , J.(10);Colombel , J.F.(1);Argmann , C.(11);Suarez-Farinas , M.(11);Petralia , F.(11);Mehandru , S.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP06: The influence of different prednisolone tapering algorithms on the effectiveness of infliximab in patients with Ulcerative Colitis – A real-world cohort study
Year: 2022
Source: ECCO'22
Authors: Ovesen, P.D.(1);Ilvemark, J.F.K.F.(1);Attauabi, M.(1);Seidelin, J.B.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP07 The epidemiology of inflammatory bowel diseases among immigrants to Denmark: A population-based cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Agrawal1, S. Shrestha2, G. Corn3, N.M. Nielsen3, M. Frisch3, J.F. Colombel1, T. Jess3

Created: Thursday, 30 January 2020, 10:12 AM
OP07: Absolute and relative risks of kidney and urological complications in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yang, Y.(1)*;Ludviggson, J.F.(1,2);Olén, O.(3,4,5);Sjölander, A.(1);Carrero, J.J.(1,6);
Created: Friday, 14 July 2023, 10:43 AM
OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Gul1, E. Jones1,2, Z. Matthews3, P. Sudhakar1,2,4, A. Treveil1,2, D. Divekar2,3, J. Buck3, M. Jefferson3, S. Armstrong5, A. Watson2,3, S. Carding2,3, U. Mayer6, P. Powell3, I. Hautefort1, T. Wileman2,3, T. Korcsmaros*1,2

Created: Friday, 22 February 2019, 9:41 AM
OP07: Artificial intelligence surpasses gastrointestinal experts in the classification of endoscopic severity among Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Lo, B.Z.S.(1);Liu, Z.(1,2);Bendtsen, F.(1);Igel, C.(2);Vind, I.(1);Burisch, J.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP07: Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial
Year: 2022
Source: ECCO'22
Authors: Schreiber, S.(1);Feagan, B.(2,3);Peyrin-Biroulet, L.(4);Vermeire, S.(5);Faes, M.(6);Harris, K.(7);Oortwijn, A.(7);Daniele, P.(8);Patel, H.(6);Danese, S.(9,10);
Created: Friday, 11 February 2022, 3:52 PM